Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2021

Nov 16, 2021

SELL
$2.38 - $3.77 $64,974 - $102,921
-27,300 Closed
0 $0
Q2 2021

Aug 16, 2021

SELL
$3.49 - $5.51 $129,828 - $204,972
-37,200 Reduced 57.67%
27,300 $100,000
Q1 2021

May 18, 2021

BUY
$5.37 - $10.72 $284,610 - $568,160
53,000 Added 460.87%
64,500 $357,000
Q4 2020

Feb 17, 2021

BUY
$3.08 - $7.79 $35,420 - $89,585
11,500 New
11,500 $87,000

Others Institutions Holding SLDB

About Solid Biosciences Inc.


  • Ticker SLDB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 7,533,080
  • Market Cap $53.2M
  • Description
  • Solid Biosciences Inc. engages in developing therapies for duchenne muscular dystrophy in the United States. The company's lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to drive functional dystrophin protein expression in patients' muscles; and SGT-003, a ext-generation gene transfer candid...
More about SLDB
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.